Shares of Aurora Cannabis Inc. (NYSE:ACB – Get Rating) have earned a consensus recommendation of “Hold” from the seven analysts that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $1.40.
ACB has been the topic of a number of research analyst reports. CIBC decreased their price objective on shares of Aurora Cannabis from C$2.25 to C$1.75 in a report on Monday, February 13th. Stifel Nicolaus dropped their target price on shares of Aurora Cannabis from C$1.75 to C$1.45 in a report on Friday, January 27th.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in ACB. Commonwealth Equity Services LLC boosted its position in Aurora Cannabis by 18.8% during the 4th quarter. Commonwealth Equity Services LLC now owns 177,313 shares of the company’s stock worth $163,000 after acquiring an additional 28,074 shares during the last quarter. Swiss National Bank lifted its holdings in Aurora Cannabis by 6.5% during the 4th quarter. Swiss National Bank now owns 728,972 shares of the company’s stock valued at $673,000 after purchasing an additional 44,300 shares during the last quarter. K2 Principal Fund L.P. acquired a new stake in Aurora Cannabis during the 4th quarter valued at $506,000. TD Asset Management Inc lifted its holdings in shares of Aurora Cannabis by 34.6% during the fourth quarter. TD Asset Management Inc now owns 241,318 shares of the company’s stock worth $223,000 after buying an additional 62,036 shares in the last quarter. Finally, Foundations Investment Advisors LLC increased its position in shares of Aurora Cannabis by 66.6% in the fourth quarter. Foundations Investment Advisors LLC now owns 125,003 shares of the company’s stock worth $115,000 after purchasing an additional 49,985 shares during the period. 13.97% of the stock is owned by institutional investors.
Aurora Cannabis Stock Down 4.4 %
ACB stock opened at $0.56 on Monday. The firm has a 50-day moving average of $0.67 and a two-hundred day moving average of $0.94. Aurora Cannabis has a 12 month low of $0.55 and a 12 month high of $3.15. The company has a current ratio of 4.08, a quick ratio of 3.16 and a debt-to-equity ratio of 0.33. The company has a market cap of $196.91 million, a price-to-earnings ratio of -0.09 and a beta of 2.57.
Aurora Cannabis (NYSE:ACB – Get Rating) last issued its quarterly earnings results on Thursday, February 9th. The company reported ($0.14) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.07). Aurora Cannabis had a negative net margin of 817.07% and a negative return on equity of 62.73%. The business had revenue of $50.95 million during the quarter, compared to analysts’ expectations of $42.60 million. As a group, analysts forecast that Aurora Cannabis will post -0.35 earnings per share for the current fiscal year.
About Aurora Cannabis
Aurora Cannabis, Inc engages in the production, distribution, and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The firm operates through the Canadian Cannabis and International Cannabis segments. Aurora Cannabis was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Recommended Stories
Receive News & Ratings for Aurora Cannabis Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Aurora Cannabis and related companies with MarketBeat.com’s FREE daily email newsletter.
ABMN Staff
Source link
